Isabelle Schwartz-Cornil
Overview
Explore the profile of Isabelle Schwartz-Cornil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
1714
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vu Manh T, Gouin C, de Wolf J, Jouneau L, Pascale F, Bevilacqua C, et al.
Cell Mol Life Sci
. 2024 Aug;
81(1):351.
PMID: 39147987
Deciphering the initial steps of SARS-CoV-2 infection, that influence COVID-19 outcomes, is challenging because animal models do not always reproduce human biological processes and in vitro systems do not recapitulate...
2.
de Wolf J, Gouin C, Jouneau L, Glorion M, Premachandra A, Pascale F, et al.
Front Immunol
. 2024 Apr;
15:1365964.
PMID: 38585271
lung perfusion (EVLP) has extended the number of transplantable lungs by reconditioning marginal organs. However, EVLP is performed at 37°C without homeostatic regulation leading to metabolic wastes' accumulation in the...
3.
Glorion M, Pascale F, Huriet M, Estephan J, Gouin C, Urien C, et al.
Front Immunol
. 2023 Nov;
14:1281546.
PMID: 37942330
Introduction: Lung transplantation often results in primary and/or chronic dysfunctions that are related to early perioperative innate allo-responses where myeloid subsets play a major role. Corticosteroids are administered upon surgery...
4.
Gouin C, Vu Manh T, Jouneau L, Bevilacqua C, de Wolf J, Glorion M, et al.
Front Immunol
. 2023 Jul;
14:1142228.
PMID: 37465668
In response to the increasing demand for lung transplantation, lung perfusion (EVLP) has extended the number of suitable donor lungs by rehabilitating marginal organs. However despite an expanding use in...
5.
Glorion M, Pascale F, Estephan J, Huriet M, Gouin C, Urien C, et al.
PLoS One
. 2023 May;
18(5):e0285724.
PMID: 37253049
Lung transplantation is the only curative option for end-stage chronic respiratory diseases. However the survival rate is only about 50% at 5 years. Although experimental evidences have shown that innate...
6.
de Wolf J, Glorion M, Jouneau L, Estephan J, Leplat J, Blanc F, et al.
Transplantation
. 2021 Sep;
106(5):979-987.
PMID: 34468431
Background: Normothermic ex vivo lung perfusion (EVLP) increases the pool of donor lungs by requalifying marginal lungs refused for transplantation through the recovery of macroscopic and functional properties. However, the...
7.
Drajac C, Laubreton D, Marquant Q, Chottin C, Ferret C, Bouguyon E, et al.
Mucosal Immunol
. 2021 Apr;
14(4):949-962.
PMID: 33846534
Respiratory Syncytial Virus (RSV) is the major cause of lower respiratory tract infection in infants, in whom, the sensing of RSV by innate immune receptors and its regulation are still...
8.
Valarcher J, Hagglund S, Naslund K, Jouneau L, Malmstrom E, Boulesteix O, et al.
Vaccines (Basel)
. 2021 Apr;
9(3).
PMID: 33803302
The induction of long-lasting clinical and virological protection is needed for a successful vaccination program against the bovine respiratory syncytial virus (BRSV). In this study, calves with BRSV-specific maternally derived...
9.
Vitour D, Doceul V, Schwartz-Cornil I, Zientara S
Virologie (Montrouge)
. 2020 Oct;
19(4):178-186.
PMID: 33065904
Upon viral infection, infected cells mount an antiviral response that culminates with the production of type I IFN (IFN-α/β) and other pro-inflammatory cytokines that control the infection. Production of type ...
10.
Riffault S, Hagglund S, Guzman E, Naslund K, Jouneau L, Dubuquoy C, et al.
Vaccines (Basel)
. 2020 May;
8(2).
PMID: 32443437
Achieving safe and protective vaccination against respiratory syncytial virus (RSV) in infants and in calves has proven a challenging task. The design of recombinant antigens with a conformation close to...